Saliva testing for the virus that causes COVID-19 is gaining acceptance in both the scientific community and US market.
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Subscribe today for access to
Articles and Reports
The FDA recently confirmed that a new rule requiring healthcare providers to notify patients of their breast density status will be released in late 2022 or early 2023.
Without abortion rights, basic lab testing applications for those who are or want to become pregnant have new and ominous legal implications.
New tool helps determine whether immunotherapy is a better option for patients than chemotherapy or radiotherapy.
In a recent report, the GAO says the agency needs a policy when it comes to enforcement discretion regarding tests approved via EUA.
While still in its infancy, recent research shows the combination of AI and wearables can accurately detect early SARS-CoV-2 infection.
New study shows that ctDNA liquid biopsy testing after stage II colon cancer may determine whether chemotherapy is required.
A new study suggests that this is a viable idea, particularly in the context of diabetes screening in a Latinx community.
Inhalers and sensors that offer digital monitoring are beginning to gain FDA approval, and could solve usage issues of traditional products.
Revised guidelines from the American Urological Association support limited use of the tests for certain prostate cancer patients.
The move comes shortly after the FDA said it was going to decline some pre-submission requests to focus on pandemic-related diagnostics.
New research led by the American Cancer Society shows decreases in cervical and breast cancer screening during the pandemic.